首页> 外文期刊>Transfusion medicine >Severe neonatal alloimmune thrombocytopaenia with anaemia.
【24h】

Severe neonatal alloimmune thrombocytopaenia with anaemia.

机译:严重的新生儿同种免疫性血小板减少症伴贫血。

获取原文
获取原文并翻译 | 示例
           

摘要

Foetaleonatal alloimmune thrombocytopaenia (FNAIT) accounts for 3% of all foetal and neonatal thrombocytopaenias and for 27% of severe cases. It arises from the destruction of foetal platelets by maternal immunoglobulin G (IgG) antibodies against antigens inherited from the father which the mother is lacking (Kaplan, 2008). Its clinical relevance subsides in the increased risk of intracranial haemorrhage (ICH) (20-30% of reported cases) which leads to death (10%) or neurological sequelae (20%). It has also been reported that 80% of ICH associated with FNAIT occur in utero, with 14% occurring before 20 weeks, 28% occurring before 30 weeks and that may be related with neurological sequelae (Burrows et ah, 1988).
机译:胎儿/新生儿同种免疫血小板减少症(FNAIT)占所有胎儿和新生儿血小板减少症的3%,严重病例占27%。它源于母体免疫球蛋白G(IgG)抗体破坏胎儿血小板的能力,该抗体针对母亲所缺乏的父亲遗传的抗原(Kaplan,2008)。其临床意义消除了颅内出血(ICH)风险增加(占报告病例的20-30%),从而导致死亡(10%)或神经系统后遗症(20%)。也有报道说,与FNAIT相关的ICH发生在子宫内,其中14%发生在子宫内,20%在20周之前发生,28%发生在30周之前,可能与神经系统后遗症有关(Burrows等,1988)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号